These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38809051)

  • 21. Diagnosing Parkinson's disease by combining neuromelanin and iron imaging features using an automated midbrain template approach.
    Jokar M; Jin Z; Huang P; Wang Y; Zhang Y; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Min J; Liu F; Chen S; He N; Haacke EM; Yan F
    Neuroimage; 2023 Feb; 266():119814. PubMed ID: 36528314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron deposition in Parkinsonisms: A Quantitative Susceptibility Mapping study in the deep grey matter.
    Fedeli MP; Contarino VE; Siggillino S; Samoylova N; Calloni S; Melazzini L; Conte G; Sacilotto G; Pezzoli G; Triulzi FM; Scola E
    Eur J Radiol; 2020 Dec; 133():109394. PubMed ID: 33190103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and diagnostic potential of R
    Beliveau V; Müller C; Steiger R; Gizewski ER; Poewe W; Seppi K; Scherfler C
    Parkinsonism Relat Disord; 2022 Aug; 101():43-48. PubMed ID: 35792337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron accumulation in the oculomotor nerve of the progressive supranuclear palsy brain.
    Lee H; Lee MJ; Kim EJ; Huh GY; Lee JH; Cho H
    Sci Rep; 2021 Feb; 11(1):2950. PubMed ID: 33536537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.
    Guan X; Xuan M; Gu Q; Huang P; Liu C; Wang N; Xu X; Luo W; Zhang M
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26853890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms.
    Mazzucchi S; Del Prete E; Costagli M; Frosini D; Paoli D; Migaleddu G; Cecchi P; Donatelli G; Morganti R; Siciliano G; Cosottini M; Ceravolo R
    Eur J Neurol; 2022 Oct; 29(10):2944-2955. PubMed ID: 35700041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating iron deposition in gray matter nuclei of patients with unilateral middle cerebral artery stenosis using quantitative susceptibility mapping.
    Mao H; Dou W; Chen K; Wang X; Wang X; Guo Y; Zhang C
    Neuroimage Clin; 2022; 34():103021. PubMed ID: 35500369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of brain iron deposition and freezing of gait in Parkinson's disease: a cross-sectional study.
    Yan Y; Wang Z; Wei W; Yang Z; Guo L; Wang Z; Wei X
    Quant Imaging Med Surg; 2023 Dec; 13(12):7961-7972. PubMed ID: 38106290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: Combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson's disease.
    He N; Ghassaban K; Huang P; Jokar M; Wang Y; Cheng Z; Jin Z; Li Y; Sethi SK; He Y; Chen Y; Gharabaghi S; Chen S; Yan F; Haacke EM
    Neuroimage; 2021 Apr; 230():117810. PubMed ID: 33524572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
    Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L
    Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.
    Li G; Tong R; Zhang M; Gillen KM; Jiang W; Du Y; Wang Y; Li J
    Neuroimage; 2023 Apr; 269():119923. PubMed ID: 36739101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-parametric radiomics of conventional T1 weighted and susceptibility-weighted imaging for differential diagnosis of idiopathic Parkinson's disease and multiple system atrophy.
    Bu S; Pang H; Li X; Zhao M; Wang J; Liu Y; Yu H
    BMC Med Imaging; 2023 Dec; 23(1):204. PubMed ID: 38066432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI-Based Radiomics of Basal Nuclei in Differentiating Idiopathic Parkinson's Disease From Parkinsonian Variants of Multiple System Atrophy: A Susceptibility-Weighted Imaging Study.
    Pang H; Yu Z; Li R; Yang H; Fan G
    Front Aging Neurosci; 2020; 12():587250. PubMed ID: 33281598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative Susceptibility Mapping in Parkinson's Disease.
    Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
    PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing Mild Cognitive Impairment in Parkinson's Disease by Magnetic Resonance Quantitative Susceptibility Mapping Combined Voxel-Wise and Radiomic Analysis.
    Zhao Y; Qu H; Wang W; Liu J; Pan Y; Li Z; Xu G; Hu C
    Eur Neurol; 2022; 85(4):280-290. PubMed ID: 35313305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson's disease patients with type 2 diabetes mellitus.
    Li W; Gao B; Du W; Jiang Y; Yang J; Hu R; Liu Y; Liu N; Zhang Y; Song Q; Miao Y
    Front Aging Neurosci; 2022; 14():975390. PubMed ID: 36177478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The applied value in brain gray matter nuclei of patients with early-stage Parkinson's disease : a study based on multiple magnetic resonance imaging techniques.
    Meng H; Zhang D; Sun Q
    Head Face Med; 2023 Jun; 19(1):25. PubMed ID: 37386479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased iron deposition of deep cerebral gray matter structures in hemodialysis patients: A longitudinal study using quantitative susceptibility mapping.
    Chai C; Wang H; Liu S; Chu ZQ; Li J; Qian T; Haacke EM; Xia S; Shen W
    J Magn Reson Imaging; 2019 Mar; 49(3):786-799. PubMed ID: 30291651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of iron metabolism markers levels of Parkinson's disease patients determined by fluid and MRI measurements.
    Xu Y; Huang X; Geng X; Wang F
    J Trace Elem Med Biol; 2023 Jul; 78():127190. PubMed ID: 37224790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different iron deposition patterns in akinetic/rigid-dominant and tremor-dominant Parkinson's disease.
    Xiong W; Li LF; Huang L; Liu Y; Xia ZC; Zhou XX; Tang BS; Guo JF; Lei LF
    Clin Neurol Neurosurg; 2020 Nov; 198():106181. PubMed ID: 33022525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.